Evaluation of the Patient Acceptable Symptom State in a pooled analysis of two multicentre, randomised, double-blind, placebo-controlled studies evaluating lumiracoxib and celecoxib in patients with osteoarthritis

Patient Acceptable Symptom State (PASS) is an absolute threshold proposed for symptomatic variables in osteoarthritis (OA) to determine the point beyond which patients consider themselves well and, as such, are satisfied with treatment. Two large previously reported studies of knee OA have shown tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Dougados, Maxime, Moore, Alan, Yu, Shaohua, Gitton, Xavier
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1860070/
https://www.ncbi.nlm.nih.gov/pubmed/17266764
http://dx.doi.org/10.1186/ar2118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1860070/
https://www.ncbi.nlm.nih.gov/pubmed/17266764
http://dx.doi.org/10.1186/ar2118

Ejemplares similares